4//SEC Filing
Regado Biosciences Inc 4
Accession 0001140361-13-034595
CIK 0001311596operating
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:41 PM ET
Size
16.6 KB
Accession
0001140361-13-034595
Insider Transaction Report
Form 4
Zelenkofske Steven
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2013-08-27+225,552→ 225,552 totalExercise: $4.00Exp: 2023-08-27→ Common Stock, par value $0.001 per share (225,552 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest as to 25% of the shares underlying the option on the one-year anniversary of the date of grant and as to 2.083% of the shares underlying the option in equal monthly installments over the subsequent 36 months.
Documents
Issuer
Regado Biosciences Inc
CIK 0001311596
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311596
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:41 PM ET
- Size
- 16.6 KB